health
fundament
global
issu
recent
outbreak
ebola
viru
diseas
middl
east
respiratori
syndrom
remind
us
global
health
issu
requir
collect
action
world
must
unit
countri
must
establish
resili
sustain
health
system
ensur
individu
secur
receiv
highest
attain
standard
health
japan
longstand
advoc
human
secur
taken
concret
action
ground
support
principl
human
secur
protect
vital
core
human
live
way
enhanc
freedom
fulfi
lment
capabl
underli
japan
polici
proactiv
contribut
peac
japan
regard
health
indispens
element
human
secur
septemb
unit
nation
gener
assembl
adopt
agenda
sustain
develop
includ
univers
health
coverag
uhc
japan
attach
great
import
negoti
process
achiev
uhc
requir
comprehens
chang
system
human
resourc
public
awar
catalys
chang
leader
must
commit
leav
one
behind
drive
best
attain
health
gain
sustain
develop
goal
sdg
creat
opportun
connect
sector
empow
individu
famili
commun
crucial
agre
monitor
evalu
framework
impact
uhc
invest
measur
thu
attain
japan
host
fi
rst
summit
adopt
sdg
may
alongsid
health
minist
meet
tokyo
intern
confer
african
develop
japan
creat
opportun
countri
partner
discuss
concret
step
toward
achiev
new
goal
share
japan
relev
experi
move
forward
togeth
new
agenda
japan
global
health
prioriti
construct
global
health
architectur
respond
public
health
crise
build
resili
sustain
health
system
realis
goal
japan
endors
two
new
global
health
strategi
basic
design
peac
health
basic
guidelin
strengthen
measur
emerg
infecti
diseas
would
like
underlin
import
prioriti
foster
succinct
relev
discuss
presid
first
prepar
summit
discuss
address
challeng
public
health
emerg
exist
global
health
architectur
must
restructur
ensur
prompt
eff
ectiv
respons
public
health
emerg
public
privat
partner
govern
civil
societyat
global
region
countri
commun
levelsshould
reach
agreement
respect
role
advanc
emerg
japan
expect
lead
role
prompt
detect
contain
especi
earli
stage
public
health
emerg
acknowledg
need
reform
capac
strengthen
japan
readi
support
reform
process
includ
launch
conting
fund
emerg
japan
also
fulli
support
eff
ort
world
bank
pandem
emerg
facil
call
coordin
world
bank
ensur
two
mechan
supplementari
complementari
role
increas
effi
cienci
eff
ectiv
crise
respons
second
discuss
strategi
build
resili
sustain
nation
health
system
past
year
japan
life
expect
increas
year
sinc
earli
health
outcom
consist
top
rank
achiev
result
establish
univers
health
insur
favour
proxim
determin
health
healthi
diet
access
clean
water
olivia
harrisreuterscorbi
action
social
determin
health
assur
equit
access
qualiti
basic
health
care
japan
improv
popul
health
outcom
boost
econom
growth
social
stabil
equiti
justic
solidar
progress
accomplish
socioeconom
develop
also
fi
rm
polit
even
countri
limit
resourc
exampl
seen
countri
kenya
japanes
offi
cial
develop
assist
loan
support
attain
uhc
pursuit
resili
sustain
health
system
intern
health
regul
ihr
also
role
reduc
risk
emerg
minimis
potenti
damag
context
support
global
health
secur
agenda
concret
mechan
strengthen
core
countri
capac
stipul
ihr
japan
well
awar
import
fi
ght
communic
diseas
tuberculosi
well
address
challeng
antimicrobi
resist
reiter
import
one
health
approach
fi
ght
antimicrobi
resist
support
countri
compli
global
action
plan
antimicrobi
resist
confi
rmed
elmau
summit
take
account
ever
expand
global
econom
integr
especi
asia
pacifi
c
region
japan
respons
address
threat
antimicrobi
resist
countri
develop
nation
action
plan
moreov
japan
world
fastestag
societi
pioneer
respons
challeng
age
extend
healthi
life
expect
maintain
sustain
health
system
basi
lifecours
approach
gener
health
care
report
advisori
panel
health
minist
japan
propos
new
health
system
goal
deliv
unmatch
health
outcom
care
sustain
contribut
prosper
japan
around
world
strengthen
health
system
aff
ord
overlook
common
asset
health
inform
system
drug
suppli
chain
establish
diseasespecifi
c
approach
reason
japan
aim
bring
togeth
expertis
resourc
includ
diseasespecifi
c
approach
donor
countri
intern
organis
includ
world
bank
global
fund
fight
aid
tuberculosi
malaria
gavi
vaccin
allianc
support
healthsystem
strengthen
develop
countri
japan
advoc
global
health
previou
summit
meet
host
includ
kyushuokinawa
hokkaidotoyako
establish
global
fund
fight
aid
tuberculosi
malaria
direct
outcom
japan
leadership
infecti
diseas
okinawa
also
led
global
health
innov
new
japan
agenc
medic
research
develop
global
health
innov
technolog
fund
addit
japan
support
global
resourc
mobilis
privat
sector
invest
around
povertyrel
infecti
diseas
eff
ort
toward
polio
erad
reiter
health
issu
pure
domest
concern
individu
countri
health
crossbord
global
challeng
urgent
work
set
framework
collabor
soon
possibl
crucial
junctur
futur
global
health
japan
host
intern
confer
univers
health
coverag
new
develop
era
dec
tokyo
leadup
japan
presid
confer
expect
highlight
global
prepared
health
emerg
well
explor
resili
sustain
health
system
sdg
world
interconnect
ever
leader
must
strive
unit
rather
divid
enhanc
human
secur
peac
pursuit
health
wellb
presid
japan
determin
contribut
galvanis
renew
momentum
global
health
peopl
receiv
basic
qualiti
servic
need
protect
health
threat
without
fi
nancial
hardship
seri
meet
next
year
intend
prove
japan
fi
rm
commit
peac
healthier
world
offi
ce
prime
minist
japan
chiyodaku
tokyo
japan
ezoesatoshi
mhlwgojp
prime
minist
japan
declar
compet
interest
agerel
macular
degener
common
caus
untreat
blind
world
preval
increas
current
therapi
neovascular
agerel
macular
degener
aim
prevent
growth
abnorm
retin
blood
vessel
could
leak
caus
rapid
visual
loss
later
stage
diseas
growth
inhibit
achiev
regular
inject
eye
molecul
block
activ
vascularendotheli
growth
factor
vegf
drug
expens
requir
regular
indefi
nite
intraocular
inject
put
substanti
strain
healthcar
resourc
lancet
elizabeth
rakoczi
colleagu
present
year
result
phase
clinic
trial
assess
singl
treatment
gene
therapi
altern
regular
inject
achiev
longterm
vegf
blockad
rakoczi
colleagu
use
adenoassoci
viral
aav
vector
deliv
gene
encod
solubl
fmsrelat
tyrosin
natur
occur
inhibitor
vegf
dose
vector
genom
vg
increas
vg
administ
singl
inject
peripher
retina
avoid
central
macula
two
group
three
patient
two
control
patient
receiv
treatment
hypothesi
transduc
cell
would
produc
suffi
cient
protein
diff
use
vitreou
inactiv
vegf
treatment
eff
ect
assess
reduct
need
inject
standard
treatment
ranibizumab
improv
retin
anatomi
year
studi
period
match
control
group
comparison
histor
data
studi
keep
treatment
eff
ect
procedur
safeti
concern
retin
ischaemia
atrophi
retin
tissu
concern
prolong
antivegf
therapi
rakoczi
colleagu
trial
notabl
explor
use
gene
therapi
mean
provid
socal
protein
pump
particularli
suit
enclos
compart
eye
although
aav
gene
therapi
shown
promis
gene
replac
singlegen
disord
use
gene
therapi
reprogramm
genet
normal
cell
retina
take
addit
function
open
new
chapter
potenti
aav
applic
one
fi
rst
trial
retin
gene
therapi
also
use
viral
vector
pharmacolog
method
sustain
deliveri
therapeut
protein
block
vegf
agerel
macular
degener
key
diff
erenc
respect
current
trial
earlier
studi
use
adenovir
vector
deliv
vegf
antagonist
predict
temporari
eff
ect
aav
vector
contrast
evolv
evad
host
immun
system
shown
evid
indefi
nite
gene
express
follow
human
subretin
administr
fi
gure
antivegf
approach
clinic
trial
includ
administr
aav
vector
directli
vitreou
caviti
rather
subretin
space
intravitr
inject
easier
perform
probabl
higher
vector
dose
would
need
could
target
eff
ect
due
transduct
retin
ganglion
cell
greater
risk
infl
ammat
studi
rakoczi
colleagu
valid
subretin
approach
howev
outstand
question
